Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KMO |
| Upstream (Parents) |
|---|
| (<<) CIDEB → KMO |
| (<<) SERPING1 → KMO |
| (<<) AQP9 → KMO |
| Downstream (Children) |
|---|
| KMO → PPAP2B (>>) |
| KMO → LHPP (>>) |
| KMO → SMPDL3A (>>) |
| KMO → APBB1IP (>>) |
| KMO → C2 (>>) |
| KMO → CD14 (>>) |
| KMO → AFAP1 (>>) |
| KMO → SSX2B///SSX2 (>>) |
| KMO → FBP1 (>>) |
| KMO → LILRA3 (>>) |
| KMO → PEPD (>>) |
| KMO → MAN1C1 (>>) |
| KMO → MARCO (>>) |
| KMO → AQP9 (>>) |
| KMO → ATRNL1 (>>) |
| KMO → APOE (>>) |
| KMO → EMR1 (>>) |
| KMO → SDS (>>) |
| KMO → TMEM140 (>>) |
